Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Study finds new drivers of destructive inflammation

Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases.

17 Dec 2019

JDRF announces more than $8 million in new funds to accelerate cutting-edge T1D research

JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced that it has committed 23 training grants, totaling more than $8 million in new funds to accelerate T1D research and the next generation of T1D experts, representing 9 states, as well as Australia, France, Canada, Germany, Denmark, Switzerland and the United Kingdom, in partnership with 20 institutions.

12 Dec 2019

The health care promises we cannot keep

It was a promise Matt Perrin wasn't able to keep. "I'll never take away your independence," he'd told his mother, Rosemary, then 71, who lived alone on Cape Cod, Mass., in a much-loved cottage.

12 Dec 2019

Study finds irregular brain function in children with Type 1 diabetes

Children with Type 1 diabetes show subtle but important differences in brain function compared with those who don't have the disease, a study led by researchers at the Stanford University School of Medicine has shown.

10 Dec 2019

Pilot clinical trial tests new treatment for type 1 diabetes

Type 1 diabetes is a chronic condition in which the body's own immune system attacks and destroys beta cells in the pancreas. Once the beta cells are destroyed, the pancreas can no longer produce insulin. Currently, there is no cure for T1D and treatment focuses on managing blood sugar levels.

6 Dec 2019

Virome analysis reveals clues for increased risk of type 1 diabetes in children

New results from The Environmental Determinants of Diabetes in the Young study show an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes.

2 Dec 2019

Leaky gut and space flight – the mechanism revealed

A new study on the effects of simulated microgravity, the condition that astronauts face in space, interferes with the epithelial barrier of the intestine, and the effect persists even after the astronaut returns to a normal environment. The research is published in the journal Scientific Reports.

28 Nov 2019

Space travel can affect intestinal function of astronauts

Bacteria, fungi, and viruses can enter our gut through the food we eat. Fortunately, the epithelial cells that line our intestines serve as a robust barrier to prevent these microorganisms from invading the rest of our bodies.

26 Nov 2019

Patients share experiences to provide insights into diabetes burnout

Essentially all patients living with type 1 diabetes experience "diabetes burnout" at some time or other.

25 Nov 2019

New partnership aims to explore, cultivate innovations in cell and gene therapy

Some patients who have not responded to traditional medicines are now experiencing remarkable recoveries thanks to next-generation immunotherapies. These therapies equip a patient's own immune cells to recognize, target, and destroy cancer cells.

25 Nov 2019

Sphingolipids associated with heart disease in African Americans with lupus

When it comes to cholesterol, we've come to accept a simple narrative. Our risk of heart disease is lower when we have more "good cholesterol," or high-density lipoproteins (HDL), and less "bad cholesterol," or low-density lipoproteins (LDL) and triglycerides.

21 Nov 2019

Rheumatoid arthritis linked to other diseases, finds new study

A study found that risk of developing rheumatoid arthritis is higher in people with certain diseases.

21 Nov 2019

Sexual dysfunction is a common complication in type 1 diabetes patients

A recent study published in Muscle & Nerve explored the prevalence of male sexual dysfunction in type 1 diabetes. Written by Ana Calzada-Reyes of Havana, Cuba, the study investigated the "prevalence of sexual dysfunction in a sample of males with type 1 diabetes."

20 Nov 2019

Rheumatoid arthritis linked to other diseases before and after diagnosis, shows study

A Mayo Clinic-led study involving 3,276 patients has found that people with inflammatory bowel disease, Type 1 diabetes or blood clots may be at increased risk of developing rheumatoid arthritis.

20 Nov 2019

PCORI Board approves $70 million to support projects designed to improve care for health conditions

The Patient-Centered Outcomes Research Institute Board of Governors today approved $70 million to fund 21 studies and related projects designed to improve care for health conditions that impose high burdens on patients, their families and the healthcare system.

19 Nov 2019

CGM alarm settings may achieve better blood sugar control for type 1 diabetes patients

Some continuous glucose monitoring (CGM) alarm features and settings may achieve better blood sugar control for people with type 1 diabetes, according to a study published in the Journal of the Endocrine Society.

19 Nov 2019

WHO announces two-year scheme to drive down the price of insulin

The World Health Organization plans to make insulin more affordable for the millions of people suffering from diabetes.

18 Nov 2019

New insights into how immune system and inflammation play a role in PD

Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.

14 Nov 2019

Study examines efficacy of nutraceuticals to manage diabetes

Every five minutes, someone in Australia is diagnosed with diabetes. It’s Australia’s fastest growing chronic condition, but as its prevalence grows more people are adding dietary supplements to their diets in the hope of reducing their risk of the disease.

14 Nov 2019

PERL study: Reducing uric acid levels does not benefit type 1 diabetes patients with kidney disease

Diabetic kidney disease remains one of the most intractable complications of diabetes. Progress has been made using glycemic and blood pressure control, but the search continues for improved treatments for the estimated one in four adults with diabetes who has some level of nephropathy and continues at risk for eventual kidney failure.

10 Nov 2019